Tetrahydrobiopterin ( BH 4 ) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock‐in mouse model
Journal of Inherited Metabolic Disease · 2024
DOI: 10.1002/jimd.12702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von Kunwar Jung-Kc und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Biopterins, Tyrosine 3-Monooxygenase, Disease Models, Animal, Phenotype. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, European Research Council, Ministerio de Economía y Competitividad.
Abstract (Originalsprache)
Proteostatic regulation of tyrosine hydroxylase (TH), the rate‐limiting enzyme in dopamine biosynthesis, is crucial for maintaining proper brain neurotransmitter homeostasis. Variants of the TH gene are associated with tyrosine hydroxylase deficiency (THD), a rare disorder with a wide phenotypic spectrum and variable response to treatment, which affects protein stability and may lead to accelerated degradation, loss of TH function and catecholamine deficiency. In this study, we investigated the effects of the TH cofactor tetrahydrobiopterin (BH 4 ) on the stability of TH in isolated protein and in DAn‐ differentiated from iPSCs from a human healthy subject, as well as from THD patients with the R233H variant in homozygosity (THDA) and R328W and T399M variants in heterozygosity (THDB). We report an increase in TH and dopamine levels, and an increase in the number of TH+ cells in control and THDA cells. To translate this in vitro effect, we treated with BH 4 a knock‐in THD mouse model with Th variant corresponding to R233H in patients. Importantly, treatment with BH 4 significantly improved motor function in these mice, as demonstrated by increased latency on the rotarod test and improved horizontal activity (catalepsy). In conclusion, our study demonstrates the stabilizing effects of BH 4 on TH protein levels and function in THD neurons and mice, rescuing disease phenotypes and improving motor outcomes. These findings highlight the therapeutic potential of BH 4 as a treatment option for THDA patients with specific variants and provide insights into the modulation of TH stability and its implications for THD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, University of Bergen, Bergen, Norway.
- K.G. Jebsen Center for Translational Research in Parkinson's Disease, University of Bergen, Bergen, Norway.
- Neurometabolic Unit and Synaptic Metabolism Lab, Neurology Department, Institut Pediàtric de Recerca and MetabERN, Hospital Sant Joan de Déu, Barcelona, Spain.
- Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
- Molecular Physiology of the Synapse, Institut de Recerca Sant Pau (IR Sant Pau), Universitat Autònoma Barcelona, Barcelona, Spain.
- Department of Pathology and Experimental Therapeutics, Bellvitge University Hospital-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
ORCID-Profile: Kunwar Jung-Kc, Alba Tristán-Noguero, Aurora Martinez
Förderung
- Instituto de Salud Carlos III
- European Research Council
- Ministerio de Economía y Competitividad
- Agencia Estatal de Investigación
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Generalitat de Catalunya
- Stiftelsen Kristian Gerhard Jebsen
- The Neuro-SysMed Center
Zitieren
APA
Jung-Kc, K., Tristán-Noguero, A., Altankhuyag, A., Piñol Belenguer, D., Prestegård, K. S., Fernandez-Carasa, I., Colini Baldeschi, A., Sigatulina Bondarenko, M., García-Cazorla, A., Consiglio, A., & Martinez, A. (2024). Tetrahydrobiopterin ( BH 4 ) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock‐in mouse model. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12702
Vancouver
Jung-Kc K, Tristán-Noguero A, Altankhuyag A, Piñol Belenguer D, Prestegård KS, Fernandez-Carasa I, et al. Tetrahydrobiopterin ( BH 4 ) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock‐in mouse model. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12702
BibTeX
@article{JungKc2024,
author = {Jung-Kc, Kunwar and Tristán-Noguero, Alba and Altankhuyag, Altanchimeg and Piñol Belenguer, David and Prestegård, Karina S and Fernandez-Carasa, Irene and Colini Baldeschi, Arianna and Sigatulina Bondarenko, Maria and García-Cazorla, Angeles and Consiglio, Antonella and Martinez, Aurora},
title = {Tetrahydrobiopterin ( BH 4 ) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock‐in mouse model},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
doi = {10.1002/jimd.12702}
}
EUVIMED